Ascend Wellness Holdings (AAWH) Net Cash Flow (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Net Cash Flow came in at -$24.8 million in Q1 2026, down 310.15% year-on-year from $11.8 million in Q1 2025, and down 1451.13% quarter-over-quarter from -$1.6 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Net Cash Flow (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Net Cash Flow history runs 7 years deep, the most recent figure standing at -$24.8 million for Q1 2026.
- On a quarterly basis, Net Cash Flow fell 310.15% year-over-year to -$24.8 million in Q1 2026; TTM through Mar 2026 was -$39.1 million, a 244.17% decrease from a year earlier, with the FY2025 full-year figure at -$2.6 million, down 116.37% from the prior year.
- Net Cash Flow retreated to -$24.8 million in Q1 2026 per AAWH's latest filing, from -$1.6 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $23.0 million in Q4 2024 and bottomed at -$49.2 million in Q3 2022.
- The 5-year median for Net Cash Flow is -$4.1 million (2023), against an average of -$5.6 million.
- Across the five-year window, Net Cash Flow plunged 346.88% in 2024 and jumped 2874.75% in 2025, its largest moves.
- Year by year, Net Cash Flow stood at -$17.2 million in 2022, then surged by 149.79% to $8.6 million in 2023, then jumped by 167.56% to $23.0 million in 2024, then slumped by 106.95% to -$1.6 million in 2025, then sank by 1451.13% to -$24.8 million in 2026.
- Per Business Quant, the three latest AAWH Net Cash Flow figures stand at -$24.8 million (Q1 2026), -$1.6 million (Q4 2025), and -$8.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | -24.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.76 Mn |
| Mar 31, 2026 | -24.76 Mn |
| Dec 31, 2025 | -1.60 Mn |
| Dec 31, 2025 | -1.60 Mn |
| Sep 30, 2025 | -8.00 Mn |
| Sep 30, 2025 | -8.00 Mn |
| Jun 30, 2025 | -4.76 Mn |
| Jun 30, 2025 | -4.76 Mn |
| Mar 31, 2025 | 11.78 Mn |
| Mar 31, 2025 | 11.78 Mn |
| Dec 31, 2024 | 22.98 Mn |
| Dec 31, 2024 | 22.98 Mn |
| Sep 30, 2024 | -18.43 Mn |
| Sep 30, 2024 | -18.43 Mn |
| Jun 30, 2024 | 10.81 Mn |
| Jun 30, 2024 | 10.81 Mn |
| Mar 31, 2024 | 396,000.00 |
| Mar 31, 2024 | 396,000.00 |
| Dec 31, 2023 | 8.59 Mn |
| Dec 31, 2023 | 8.59 Mn |